Robert Hershberg

Robert Hershberg has a long history of experience in the pharmaceutical and healthcare industry. Robert is currently the Co-Founder, CEO and Chairman of the Board of HilleVax, a Venture Partner at Frazier Life Sciences, Co-Founder, Executive Chairman of the Board at Cajal Neuroscience, and was previously the Executive Vice President, Head of Business Development and Global Alliances, Executive Vice President, Chief Scientific Officer, and Senior Vice President, Immuno-Oncology at Celgene from 2014 to 2020. Robert was also the Chief Executive Officer of VentiRx Pharmaceuticals from 2012 to 2020, President and Chief Medical Officer and Co-Founder, Executive Vice President, Research and Development from 2006 to 2012, and Chief Medical Officer of Dendreon from 2003 to 2006.

Robert Hershberg received an MD, PhD in Medicine/Biology from the University of California, Los Angeles in 1992.